Z79.621

✓ Billable

Long term (current) use of calcineurin inhibitor

Factors influencing health status and contact with health services (Z00-Z99)

Check This Code

Also Known As

Long term (current) use of cyclosporineLong term (current) use of tacrolimus

⚠️ Excludes2

inherited

Rules inherited from parent codes.

  • long term (current) use of steroids (Z79.5-)
  • long term (current) use of agents affecting estrogen receptors and estrogen levels (Z79.81-)
  • drug abuse and dependence (F11-F19)
  • drug use complicating pregnancy, childbirth, and the puerperium (O99.32-)

Clinical Description

ICD-10-CM code Z79.621 represents long term (current) use of calcineurin inhibitor. This code falls under the Factors influencing health status and contact with health services (Z00-Z99) classification. It is a billable/specific code valid for HIPAA-covered transactions as of October 1, 2025 (FY2026). This code can be used to indicate a diagnosis for reimbursement purposes on insurance claims.

This is a 7-character code at the 6th level of specificity. This is the most specific code available in this subcategory.

Frequently Asked Questions

What is ICD-10 code Z79.621?

ICD-10-CM code Z79.621 is "Long term (current) use of calcineurin inhibitor". It belongs to the category: Factors influencing health status and contact with health services (Z00-Z99).

Is Z79.621 a billable ICD-10 code?

Yes, Z79.621 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

Can Z79.621 be coded with other codes?

Z79.621 has 4 Excludes2 note(s). These conditions can be coded together if both are documented in the patient record.

🧪 Validate Combinations

Add Z79.621 to the Excludes Checker to validate against your full code list.

Open in Checker →

Code Information

CodeZ79.621
BillableYes
ParentZ79.62
CategoryFactors influencing health status and contact with health services (Z00-Z99)
Excludes10 rule(s)
Excludes24 note(s)

Data Source

CMS ICD-10-CM 2026 Tabular List

Updated October 1, 2025 (FY2026)